Managing Medical Risk In Patients Seeking Psilocybin Therapy is a comprehensive 2-hour online, CME/CE accredited course designed for healthcare providers interested in broadening their knowledge about this innovative therapeutic option. This comes in response to the emerging research on the medical benefits of psilocybin and its increased approval for medicinal uses in states like Oregon and Colorado, which have spurred a growing number of patients to consider psilocybin-assisted therapy for various health conditions.
The course aims to fill an information gap in the medical community, as many healthcare professionals have not been trained to effectively assess the medical risks associated with psilocybin therapy. This self-paced program provides participants with the tools they need to safely and comfortably evaluate and discuss the relevant medical risks with their patients.
The curriculum is structured into four key modules: ‘Background on Psilocybin’, ‘Psilocybin Legality & the Oregon Psilocybin Services Act’, ‘Research-Investigated Indications’, and ‘Managing Medical Risk in Patients Seeking Psilocybin Therapy’. These modules offer a thorough understanding of the basics of psilocybin therapy, its pharmacology, potential drug-drug interactions, the clinical indications for which it has shown promise, and contraindications to its use. It also explores the historical use of psilocybin and how it affects the mind and body.
This course is especially beneficial for primary care providers for adults and psychiatric health practitioners seeking to deepen their insights into the burgeoning field of psychedelic medicine. Upon completion, participants who pass the course are also offered the opportunity to list themselves in the PMA’s Directory of Psilocybin-Informed Clinicians, a first-of-its-kind directory. This allows patients who need a risk assessment before starting psilocybin therapy to easily find a qualified clinician and offers practitioners a unique platform to connect and share knowledge within a broader community.
Find More Info on Managing Medical Risk In Patients Seeking Psilocybin Therapy on PsychedelicsCourses.com
Related Company
Psychedelic Medicine Association
The Psychedelic Medicine Association (PMA) is a public benefit corporation that unites healthcare providers in the psychedelics field. The primary aim is education, but they probably don't shy away from providing some good PR for the field.